First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

A. -M. C. Dingemans, Adrianus J. de Langen, V. van den Boogaart, Johannes T. Marcus, W. H. Backes, H. T. G. M. Scholtens, H. van Tinteren, Otto S Hoekstra, Jan Pruim, B. Brans, F. B. Thunnissen, E. F. Smit, H. J. M. Groen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)559-566
JournalAnnals of Oncology
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 2011

Keywords

  • bevacizumab
  • chemonaive
  • erlotinib
  • imaging
  • NSCLC
  • phase II

Cite this